Oaktree Specialty Lending Earnings Call Transcripts
Fiscal Year 2026
-
Non-accruals declined to 1.8% of the portfolio, with strong liquidity and stable NAV. Adjusted net investment income was $32.2 million, and new investments yielded higher spreads. Management remains cautious amid macro headwinds and sees opportunity in private credit.
-
Non-accruals and software exposure were reduced, while liquidity and portfolio quality improved. NAV and net investment income declined due to mark-to-market write-downs, but wider spreads and better deal protections support a positive outlook.
-
The meeting covered director elections and auditor ratification, with both proposals approved by stockholders. No questions were raised by participants, and the meeting concluded smoothly.
-
Q1 2026 saw stable earnings and a modest rise in net investment income, with strong capital deployment and a growing portfolio. Non-accruals declined year-over-year, but NAV per share fell due to markdowns, notably in Pluralsight. Spreads are expected to remain stable, with continued focus on resilient sectors.
Fiscal Year 2025
-
Q4 adjusted net investment income rose to $0.40 per share, with reduced non-accruals and strong new investment activity. NAV per share dipped slightly due to unrealized depreciation, and lower base rates are expected to pressure income next quarter.
-
NAV increased slightly, while adjusted net investment income declined due to non-recurring refinancing costs and lower non-recurring income. Portfolio quality improved with reduced non-accruals, and ample liquidity supports future growth. Credit spreads tightened, but private credit remains attractive.
-
Adjusted NII was $44.7M ($0.54/share), with NAV per share down to $17.63. Oaktree injected $100M at NAV, boosting liquidity and signaling support. Portfolio remains diversified, with 82% first-lien positions and a positive outlook for 2025 deal flow.
Fiscal Year 2024
-
Q4 adjusted NII was $45 million ($0.55/share), flat sequentially, with a slight NAV per share decline and increased non-accruals. Portfolio remains 82% first-lien, and liquidity is strong. Management expects increased deal activity and remains cautious on refinancing risks.
-
Adjusted NII per share declined slightly to $0.55 amid higher non-accruals and NAV decrease, but strong origination and portfolio rotation to first lien loans continued. A one-time $3.2M fee waiver and a permanent management fee cut are expected to boost future income.